Votes and comments are community opinion, not professional advice.

High risk · Not financial advice

📈b/stocksCommunity for Stocks

Buying SELLAS after a 200% one-day pop on its cancer vaccine news is how retail becomes exit liquidity

u/askedonce· 3 hours agoClaimNo receipts
LEGITSKETCHYTOTAL CAP
UNRATED

Community vote

No Bro-Meter votes yet. Be the first. The verdict is only these votes — not FDA pages, imports, or ads.

Tried-it reports

Lived experience sits next to the community vote. Official sources never override either.

Tap a verdict. It counts right away, no sign-up needed.

SELLAS Life Sciences says its Phase 3 trial of galinpepimut-S in acute myeloid leukemia patients in second or later remission who couldn't get a stem cell transplant cut the risk of death by 41%. The stock reportedly ran more than 200% on the news. Biotech traders on X are fighting about it. Bulls say a positive Phase 3 in a disease with few options is exactly the kind of catalyst that re-rates a small cap for good, and the move isn't done. Bears say small biotechs that triple on data almost always raise money right after, dilute everyone who chased, and give back a big chunk before approval is anywhere close. Still early, or already too late to buy?

00
Share verdictShare on XVerdict card
Next claimNvidia's $115.8B quarter and $130B guide prove the AI bubble crowd was wrong, even without Jensen

Votes and comments are community opinion, not professional advice.

Comments (1)

  • u/chartjunkie

    watch for the offering. it's always the offering

    0

More claims to call

b/stocks →